Physician profile
Gary E Nelson
NPI 1629035795
$1,248.22
in general payments reported to CMS, 2019-2025
16 companies · $53.19 in 2025
The $53.19 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $350 · 2023: $56.97 · 2024: $564 · 2025: $53.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $364.17 | 2021-2024 | Farxiga |
| Abbvie INC. | $317.21 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $119.84 | 2024 | Voquezna |
| Boston Scientific Corporation | $116.18 | 2023-2024 | Watchman Flx, Wavewriter Alpha Prime 16 |
| Inspire Medical Systems, INC. | $83.52 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $64.16 | 2022 | |
| Astellas Pharma US INC | $29.62 | 2025 | Veozah |
| Alkermes, INC. | $25.45 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.00 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $19.32 | 2022 | |
| Dynavax Technologies Corporation | $16.30 | 2022 | |
| Lucid Diagnostics INC. | $15.81 | 2022 | |
| Corcept Therapeutics | $15.68 | 2024 | Korlym |
| Novo Nordisk INC | $14.48 | 2024 | Rybelsus, Ozempic |
| Pfizer INC. | $13.96 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.